Zhejiang Huakang Pharmaceutical Co., Ltd. reported earnings results for the third quarter ended September 30, 2021. For the third quarter, the company reported sales was CNY 1,187.93 million compared to CNY 988.3 million a year ago. Revenue was CNY 1,187.93 million compared to CNY 988.3 million a year ago.

Net income was CNY 183.7 million compared to CNY 233.9 million a year ago. Basic earnings per share from continuing operations was CNY 0.8357 compared to CNY 1.3674 a year ago. Diluted earnings per share from continuing operations was CNY 0.8357 compared to CNY 1.3674 a year ago.